Key references: Summary of menopause management

Baber RJ, Panay N, Fenton A, Group IMSW. IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016 2016 ;19(2):109–50. https://www.ncbi.nlm.nih.gov/pubmed/26872610
Boardman HM, Hartley L, Eisinga A, Main C, Roque i Figuls M, Bonfill Cosp X, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;(3):CD002229. https://www.ncbi.nlm.nih.gov/pubmed/25754617
Gazarra LBC, Bonacordi CL, Yela DA, Benetti-Pinto CL. Bone mass in women with premature ovarian insufficiency: a comparative study between hormone therapy and combined oral contraceptives. Menopause 2020. https://www.ncbi.nlm.nih.gov/pubmed/32576798
POI Guideline Development Group. Management of women with premature ovarian insufficiency. Guideline of the European Society of Human Reproduction and Embryology (ESHRE). Grimbergen, Belgium: ESHRE; 2015. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Management-of-premature-ovarian-insufficiency.aspx
Segan L, Burgess S, Zaman S. Closing the gap for women with coronary artery disease. Medicine Today 2020;21(1):12–22. https://medicinetoday.com.au/2020/january/feature-article/closing-gap-women-coronary-artery-disease